Paper40873643
Emerging Target Discovery Strategies Drive the Decoding of Therapeutic Power of Natural Products and Further Drug Development: A Case Study of Celastrol.
Tu Y and 5 others. Exploration (Beijing), 2025. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. Emerging Target Discovery Strategies Drive the Decoding of Therapeutic Power of Natural Products and Further Drug Development: A Case Study of Celastrol. Papers, record 40873643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40873643
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Emerging Target Discovery Strategies Drive the Decoding of Therapeutic Power of Natural Products and Further Drug Development: A Case Study of Celastrol.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References131
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19858214 | Characterization of celastrol to inhibit hsp90 and cdc37 interaction. | J Biol Chem | 2009 | https://conductscience.org/library/papers/19858214 | PubMed |
| 2 | 36076154 | Celastrol Targets Cullin-Associated and Neddylation-Dissociated 1 to Prevent Fibroblast-Myofibroblast Transformation against Pulmonary Fibrosis. | ACS Chem Biol | 2022 | https://conductscience.org/library/papers/36076154 | PubMed |
| 3 | 38044218 | Integrated network pharmacology and metabolomics reveal the action mechanisms of vincristine combined with celastrol against colon cancer. | J Pharm Biomed Anal | 2024 | https://conductscience.org/library/papers/38044218 | PubMed |
| 4 | 38747156 | Reducing Peptidoglycan Crosslinking by Chemical Modulator Reverts β-lactam Resistance in Methicillin-Resistant Staphylococcus aureus. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/38747156 | PubMed |
| 5 | 38434700 | Recent advances in drug delivery of celastrol for enhancing efficiency and reducing the toxicity. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/38434700 | PubMed |
| 6 | 28644690 | Advances in the development of human protein microarrays. | Expert Rev Proteomics | 2017 | https://conductscience.org/library/papers/28644690 | PubMed |
| 7 | 28388439 | Celastrol-Induced Nur77 Interaction with TRAF2 Alleviates Inflammation by Promoting Mitochondrial Ubiquitination and Autophagy. | Mol Cell | 2017 | https://conductscience.org/library/papers/28388439 | PubMed |
| 8 | 35538061 | Artificial intelligence in cancer target identification and drug discovery. | Signal Transduct Target Ther | 2022 | https://conductscience.org/library/papers/35538061 | PubMed |
| 9 | 27273088 | Induction of heat shock proteins in differentiated human neuronal cells following co-application of celastrol and arimoclomol. | Cell Stress Chaperones | 2016 | https://conductscience.org/library/papers/27273088 | PubMed |
| 10 | 28757108 | Celastrol synergizes with oral nifedipine to attenuate hypertension in preeclampsia: a randomized, placebo-controlled, and double blinded trial. | J Am Soc Hypertens | 2017 | https://conductscience.org/library/papers/28757108 | PubMed |
| 11 | 39494324 | Recent Trends in anti-tumor mechanisms and molecular targets of celastrol. | Int J Biol Sci | 2024 | https://conductscience.org/library/papers/39494324 | PubMed |
| 12 | 36809500 | Challenges and Perspectives in Target Identification and Mechanism Illustration for Chinese Medicine. | Chin J Integr Med | 2023 | https://conductscience.org/library/papers/36809500 | PubMed |
| 13 | 36386476 | PROTAC technology as a novel tool to identify the target of lathyrane diterpenoids. | Acta Pharm Sin B | 2022 | https://conductscience.org/library/papers/36386476 | PubMed |
| 14 | 38276299 | Celastrol Stabilizes Glycolipid Metabolism in Hepatic Steatosis by Binding and Regulating the Peroxisome Proliferator-Activated Receptor γ Signaling Pathway. | Metabolites | 2024 | https://conductscience.org/library/papers/38276299 | PubMed |
| 15 | 37455458 | Recent Advances on PKM2 Inhibitors and Activators in Cancer Applications. | Curr Med Chem | 2024 | https://conductscience.org/library/papers/37455458 | PubMed |
| 16 | 33870466 | Comparative transcriptomics and network pharmacology analysis to identify the potential mechanism of celastrol against osteoarthritis. | Clin Rheumatol | 2021 | https://conductscience.org/library/papers/33870466 | PubMed |
| 17 | 29355035 | Simultaneous targeting therapy for lung metastasis and breast tumor by blocking the NF-κB signaling pathway using Celastrol-loaded micelles. | Drug Deliv | 2018 | https://conductscience.org/library/papers/29355035 | PubMed |
| 18 | 36231136 | Mitochondrial VDAC1: A Potential Therapeutic Target of Inflammation-Related Diseases and Clinical Opportunities. | Cells | 2022 | https://conductscience.org/library/papers/36231136 | PubMed |
| 19 | 37216761 | CETSA and thermal proteome profiling strategies for target identification and drug discovery of natural products. | Phytomedicine | 2023 | https://conductscience.org/library/papers/37216761 | PubMed |
| 20 | 33107103 | HMGB1 as a therapeutic target in disease. | J Cell Physiol | 2021 | https://conductscience.org/library/papers/33107103 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42943713 | Celastrol and Its Derivatives in Breast, Ovarian, and Cervical Cancer: Molecular Targets, Signalling Networks, and Nanocarrier-Based Delivery. | Molecules | 2026 | https://conductscience.org/library/papers/42943713 | PubMed |
| 42942746 | Lycopene-Mediated Modulation of Apoptosis and Survival Signalling in Cancer: Emerging Nanodelivery Strategies and Translational Limitations. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42942746 | PubMed |
| 42797540 | Celastrol Attenuates Doxorubicin-Induced Heart Failure by Preserving Mitochondrial Integrity and Suppressing Oxidative Stress and Is Accompanied by Changes in Gut Microbiota. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42797540 | PubMed |
| 42723168 | Beyond Biomimetics: Pathology-Informed Engineering Rescues Reconstituted HDL From Inflammatory Dysfunction for Sepsis Immunotherapy. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42723168 | PubMed |
| 42699116 | Emerging natural product development strategies drive the therapeutic potential exploration and clinical translation of hydroxysafflor yellow A. | J Pharm Anal | 2026 | https://conductscience.org/library/papers/42699116 | PubMed |
| 42589627 | A Heterogeneous Codonopsis pilosula Polysaccharide Preparation Attenuates Doxorubicin-Induced Cardiotoxicity in Mice: Associations with Oxidative Stress, Mitochondrial Function, and Gut Microbiota. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42589627 | PubMed |
| 42368570 | Advanced drug delivery platforms targeting cellular senescence: A promising strategy for cancer therapy. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42368570 | PubMed |
| 42193972 | The Antitumor Potential of Celastrol: Research Progress on Antitumor Mechanisms and Strategies for Toxicity Reduction with Efficacy Enhancement. | Biomolecules | 2026 | https://conductscience.org/library/papers/42193972 | PubMed |
| 42035528 | Targeted intestinal delivery of luteolin microcapsules as a precision nutritional strategy to alleviate heat stress and enhance growth performance in broilers. | Poult Sci | 2026 | https://conductscience.org/library/papers/42035528 | PubMed |
| 41977114 | Eriodictyol in Cancer Therapy: Reviewing Mechanistic Insights and Translational Opportunities. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41977114 | PubMed |
| 41751423 | From Gas Chromatography-Mass Spectrometry (GC-MS) to Network Pharmacology: System-Level Insights into the Multi-Target Biological Potential of Flaveria trinervia (Spreng.) C. Mohr. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/41751423 | PubMed |
| 41599652 | Hepatoprotection by Naringin Nanoliposomes Against Nickel Toxicity Involves Antioxidant Reinforcement and Modulation of Nrf2, NF-κB, PI3K/mTOR, JAK/STAT, and Apoptotic Pathways. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41599652 | PubMed |
| 41395244 | Celastrol Inhibits Porcine Epidemic Diarrhea Virus Replication by Promoting ROS-Mediated Apoptosis. | Transbound Emerg Dis | 2025 | https://conductscience.org/library/papers/41395244 | PubMed |
| 41201036 | Role of ubiquitin‑proteasome system in preeclampsia (Review). | Mol Med Rep | 2026 | https://conductscience.org/library/papers/41201036 | PubMed |
| 41146125 | Mechanism by which CAP regulates the "cold-heat" balance in osteosarcoma model mice: an integrative study of metabolomics, transcriptomics, and network pharmacology. | J Transl Med | 2025 | https://conductscience.org/library/papers/41146125 | PubMed |
| 40873643 | Emerging Target Discovery Strategies Drive the Decoding of Therapeutic Power of Natural Products and Further Drug Development: A Case Study of Celastrol. | Exploration (Beijing) | 2025 | https://conductscience.org/library/papers/40873643 | PubMed |
| 40493718 | Real-Time Intracellular Monitoring of miRNA Dynamics during Induced Pluripotent Stem Cell Neuronal Differentiation via Plasmon-Enhanced Nanobiosensing. | Nano Lett | 2025 | https://conductscience.org/library/papers/40493718 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| HMGB1 | 3146 | PubTator's text mining | https://conductscience.org/library/genes/3146 | NCBI Gene |
| HSP90AA1 | 3320 | PubTator's text mining | https://conductscience.org/library/genes/3320 | NCBI Gene |
| PKM | 5315 | PubTator's text mining | https://conductscience.org/library/genes/5315 | NCBI Gene |
| STAT3 | 6774 | PubTator's text mining | https://conductscience.org/library/genes/6774 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40873643
GET https://conductscience.org/api/papers/v1/40873643/references?page=2